New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Celeros Separations
- 4227 Surles Court
- Durham NC, 27703
- UNITED STATES
Celeros delivers advanced equipment to enable biotech and pharmaceutical organizations to significantly improve their processes, increase yields and reduce costs. Based on well-protected and differentiated proprietary Automatic Piston Discharge (APD) technology, Celeros innovations provide real advantages for demanding Biotech and pharmaceutical separation customers worldwide.